Clinical Trial Update: A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan

View source ↗

Summary

This is a completed real-world clinical trial evaluating the combination of nivolumab and ipilimumab for advanced or metastatic renal cell carcinoma in Japan. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced or Metastatic Renal Cell Carcinoma | Status: COMPLETED